Dear Shareholder (s),
Kindly note that SEBI vide circular no. SEBI/ HO/ OIAE/OIAE_IAD-1/ P/ CIR/ 2023/ 131 on July 31, 2023 has introduced Online Dispute Resolution (ODR) mechanism to facilitate online resolution of all kinds of disputes arising in the Indian securities market.
To enhance investor awareness on the ODR mechanism, a brief overview of the process is provided for your easy reference:
Level 1: Raise your concerns with Registrar and Transfer Agent (RTA)/ Company
As a first step, all grievances/ disputes/ complaints against the Company are required to be directly lodged with RTA &/ or Company.
In the case of Strides, Kfin Technologies is our RTA and Shareholders may lodge their concerns by sending an email to einward.ris@kfintech.com or by sending physical correspondence at:
KFIN Technologies Limited
Unit: Strides Pharma Science Limited
Selenium Tower B, Plot 31-32,
Gachibowli, Financial District, Nanakramguda,
Hyderabad – 500 032
Toll Free No.: 1- 800-309-4001
You can also write to the Company at investors@strides.com
Level 2: SEBI SCORES
Grievances/ disputes/ complaints which are not resolved at Level 1, or if the shareholder is not satisfied with the resolution provided by the Company/ RTA, then a complaint may be raised on SEBI Complaints Redress System (“SCORES”) which can be accessed at https://www.scores.gov.in.
Level 3: ODR Mechanism
In case the Shareholder is not satisfied with the resolution provided at Level 1 or 2, then the Online Dispute Resolution process may be initiated through the ODR Portal at https://smartodr.in/login within the applicable timeframe under law.
The link to the ODR Portal is also displayed on our website at https://www.strides.com/
Important Notes:
The aforesaid SEBI circular/ corrigendum can be accessed on the website of SEBI at https://www.sebi.gov.in/ or on the website of the Company at https://www.strides.com/ODR_Mechanism.html
For any queries on the above matter, investors may contact the Company's Registrar & Share Transfer Agent, KFin Technologies Limited at einward.ris@kfintech.com or the Company at investors@strides.com
Thanks and Regards,
For Strides Pharma Science Limited
Sd/-
Manjula Ramamurthy
Company Secretary